Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 1 - 10 of 91 |
Associate Director, Global Labeling
Cambridge, Massachusetts
Alnylam is seeking an experienced labeling professional to join our labeling strategy team. This team is responsible for developing initial product label content and strategy through the Target Label Process (TLP). The ideal candidate will ...
17h
| Job Type | Full Time |
Associate Director, Regulatory Affairs, CMC- Biologics
Cambridge, Massachusetts
Overview The Associate Director, Regulatory Affairs CMC Development is responsible for developing and implementing global CMC regulatory strategies for development-stage programs. This role will play a critical part in shaping regulatory st...
17h
| Job Type | Full Time |
Senior Director Biostatistics Head of Statistical Innovation & Methodology
Cambridge, Massachusetts
Senior Director Biostatistics, Head of Statistical Innovation & Methodology Overview At Alnylam, the Senior Director Biostatistics, Head of Statistical Innovation & Methodology will provide scientific leadership in advanced statistical meth...
17h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview Alnylam, a leading biotechnology company, is looking for a Paralegal to join its Legal Department. This role is reporting to the SVP, General Counsel, Governance and Corporate, and is based at the company's headquarters in Cambridg...
17h
| Job Type | Full Time |
Associate Director, Statistical Programming
Cambridge, Massachusetts
The Associate Director, Statistical Programming is responsible for statistical programming activities in support of clinical trials including technical and project leadership overseeing the quality and timely delivery of all statistical pro...
17h
| Job Type | Full Time |
Director, Enterprise Learning & Development
Cambridge, Massachusetts
Overview Alnylam is seeking a Director of Enterprise Learning & Development to shape the future of learning at scale. This role will lead the evolution of how professional skills and capabilities are developed across the organization, ensur...
17h
| Job Type | Full Time |
Cambridge, Massachusetts
The Global Medical Director, Early Assets will report to the VP, Early Assets and will be responsible for developing, leading, and executing the medical strategy and scientific engagement for multiple early-stage CNS clinical programs, incl...
17h
| Job Type | Full Time |
Senior Director, Clinical Pathology
Cambridge, Massachusetts
Summary of Key Responsibilities: Clinical pathology assessment of preclinical results for platform and program support Review non-GLP and GLP study clinical pathology data Clearly interpret and report findings and position significance to p...
17h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview The mission ofDMPKis to enable efficient and successful drug discovery and development of siRNA and other therapeutic candidates by characterizing and interpreting ADME (absorption, distribution, metabolism, and excretion) and PK/P...
17h
| Job Type | Full Time |
Business Account Executive, TTR - Trenton, NJ
Cambridge, Massachusetts
Overview: We are looking for experienced Business Account Executives (BAEs) with specialty sales experience to promote AMVUTTRA. Patients with TTR amyloidosis often spend years undiagnosed and misdiagnosed. This is an amazing opportunity to...
17h
| Job Type | Full Time |